DIA435.72-5.61 -1.27%
SPX6,238.01-101.38 -1.60%
IXIC20,650.13-472.32 -2.24%

This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Benzinga·03/25/2025 14:57:05
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Morgan Stanley analyst Bob Huang downgraded the rating for Brown & Brown, Inc. (NYSE:BRO) from Overweight to Equal-Weight and maintained the price target of $128. Brown & Brown shares closed at $120.98 on Monday. See how other analysts view this stock.
  • Jefferies analyst Surinder Thind downgraded Dun & Bradstreet Holdings, Inc. (NYSE:DNB) from Buy to Hold and cut the price target from $11 to $9.15. Dun & Bradstreet shares closed at $8.99 on Monday. See how other analysts view this stock.
  • Leerink Partners analyst Marc Goodman downgraded Opthea Limited (NASDAQ:OPT) from Outperform to Market Perform and lowered the price target from $12 to $1. Opthea shares closed at $3.36 on Monday. See how other analysts view this stock.
  • Citigroup analyst Anthony Pettinari downgraded the rating for The AZEK Company Inc. (NYSE:AZEK) from Buy to Neutral and lowered the price target from $61 to $51.5. AZEK shares closed at $48.56 on Monday. See how other analysts view this stock.
  • Stephens & Co. analyst Mason Carrico downgraded Akoya Biosciences, Inc. (NASDAQ:AKYA) from Overweight to Equal-Weight and slashed the price target from $3.5 to $1.8. Akoya Biosciences shares closed at $1.67 on Monday.  See how other analysts view this stock.

Considering buying BRO stock? Here’s what analysts think:

Read This Next:

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.